Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FNTA | P49354 | 10/20 | 0.52 |
| ▸ | FNTB | P49356 | 10/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.51 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.43 |
| ▸ | NPC1 | O15118 | 2/20 | 0.41 |
| ▸ | RAB9A | P51151 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | MAOA | P21397 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | GLA | P06280 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27211517 | 0.89 | FNTA (0.52) | FNTAFNTBALDH1A1KDM4EMAPT | |
| SCHEMBL27211444 | 0.89 | ALDH1A1 (0.51) | FNTAFNTBALDH1A1NPC1RAB9A | |
| SCHEMBL27211503 | 0.88 | BCHE (0.52) | FNTAFNTBALDH1A1NPC1RAB9A | |
| SCHEMBL26829996 | 0.83 | ALDH1A1 (0.52) | FNTAFNTBALDH1A1MAPK1NPC1 | |
| SCHEMBL27211468 | 0.76 | ALDH1A1 (0.47) | FNTAFNTBALDH1A1NPC1KDM4E | |
| SCHEMBL24748608 | 0.74 | FNTA (0.44) | FNTAFNTBMAPK1NPC1RAB9A | |
| SCHEMBL26830001 | 0.74 | ALDH1A1 (0.54) | FNTAFNTBALDH1A1RAB9AKDM4E | |
| SCHEMBL29766498 | 0.73 | ALDH1A1 (0.56) | FNTAFNTBALDH1A1MAPK1KDM4E | |
| SCHEMBL27165736 | 0.72 | FNTA (0.54) | FNTAFNTBALDH1A1MAPK1KDM4E | |
| SCHEMBL26829994 | 0.72 | ALDH1A1 (0.52) | FNTAFNTBALDH1A1RAB9AKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11976066-B1 | Substituted 7-amino-3-(substituted benzoyl)indolizine-1-carboxylates as anti-tubercular agents | King Faisal University (SA) | 2024-05-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11976066-B1 | Substituted 7-amino-3-(substituted benzoyl)indolizine-1-carboxylates as anti-tubercular agents | BET1, INMT, IDO1 | FNTA 1028/4885FNTB 391/4885ALDH1A1 612/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.